To further explore the molecular mechanism of immunochemotherapy in advanced NKTL, 446 lymphoma- and cancer-relevant genes using next-generation sequencing (NGS) were analyzed in seven patients with available tumor tissues. This evidence concerns the gene SCYL1 and lymphoma.